NNCSF (Nanosonics) Total Equity: $146.0 Mil (As of Dec. 2025)


NNCSF Nanosonics Ltd NNCSF
90 GF Score
Price $2.55
GF Value $3.58
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Nanosonics Total Equity?

Nanosonics NNCSF 90 Total Equity is $146.0 Mil as of Dec. 2025. GuruFocus rates NNCSF with a GF Score™ of 90/100 and a GF Value™ of $3.58 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Nanosonics's total equity for the quarter that ended in Dec. 2025 was $146.0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Nanosonics Total Equity Historical Data

* Premium members only.

The historical data trend for Nanosonics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanosonics Total Equity Chart

Nanosonics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.65 97.46 109.97 120.98 136.66

Nanosonics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.49 120.98 119.71 136.66 145.97
NNCSF
90GF Score
Nanosonics Ltd NNCSF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanosonics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Nanosonics's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=177.397-40.737
=136.7

Nanosonics's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=185.551-39.577
=146.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $146.0 Mil mean?
Nanosonics (NNCSF) has a Total Equity of $146.0 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Nanosonics and its competitors.
Is Nanosonics' Total Equity too high?
Nanosonics' current Total Equity is $146.0 Mil. Overall, Nanosonics has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nanosonics' Total Equity compare to ISRG and BDX?
Nanosonics' Total Equity of $146.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Nanosonics and its competitors. Nanosonics's current Total Equity is $146.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanosonics stock overvalued right now?
Based on GuruFocus' analysis, Nanosonics (NNCSF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.58, compared to a current price of $2.55 — trading 28.8% below its estimated fair value. The current Total Equity is $146.0 Mil. Nanosonics' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Nanosonics (NNCSF), the current Total Equity is $146.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanosonics (NNCSF) Overvalued in 2026?

Based on GuruFocus' analysis, Nanosonics stock appears to be undervalued. The current stock price of $2.55 is trading 28.8% below its estimated GF Value™ of $3.58. GuruFocus considers Nanosonics to be Modestly Undervalued.

Key valuation signals for NNCSF:

  • Total Equity: $146.0 Mil
  • GF Value™: $3.58 vs. price of $2.55 (28.8% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the NNCSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanosonics Business Description

Other Exchanges NAN:Australia
Address 7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113
Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics' revenue consists of capital sales of Trophon units, ongoing consumables sales, and service revenue. By December 2025, there were 38,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.
90GF Score

Get the complete analysis for NNCSF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.55
Price
$3.58
GF Value